Agent Trial
Trading Prediction Markets AI Agent Context Fastest News API Agent Trial Log In Sign Up
News Wire / science

Antibiotic Combo Shows Promise Against Resistant E. coli

Bluesky Social 1h Impact 5
A combination of amikacin and ceftazidime/avibactam killed over 4 log10 CFU/mL of E. coli with IMP-4 in 48 hours. This effect lasted for seven days, with monotherapies regrowing.

Topics

antibiotics drug resistance E. coli

Developing

  1. 882d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
  2. 882d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
  3. 882d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
  4. 882d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.

Sources · 7 independent

Bluesky Social

“combo amikacin + ceftazidime/avibactam killed >4 log10 CFU/mL E. coli with IMP-4 in 48h, lasting 7 days.”

Unlock the full story

Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.

Log in to upgrade